Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,212.00
Bid: 12,212.00
Ask: 12,216.00
Change: 150.00 (1.24%)
Spread: 4.00 (0.033%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares reach record high, oil tops $60 a barrel

Mon, 08th Feb 2021 13:05

* MSCI all-country world share index at record high

* European indexes climb early on, U.S. futures gain

* Oil crosses $60 a barrel

* Hopes of $1.9 trln U.S. stimulus, vaccines boosting
sentiment

* U.S. dollar retreats from recent highs

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2021 http://tmsnrt.rs/2egbfVh

*

By Marc Jones

LONDON, Feb 8 (Reuters) - World shares set another record
high on Monday and oil surpassed $60 a barrel for the first time
in a year, on hopes that a $1.9 trillion COVID-19 aid package
will be passed by U.S. lawmakers as soon as this month.

Even news that South Africa had halted the rollout of
AstraZeneca's vaccine after a study showed it gave only limited
protection against the country's more contagious variant of the
virus wasn't going to put equity markets off.

MSCI's 50-country index of world stocks hit
its ninth record high of 2021 overnight as Tokyo's Nikkei
jumped on talk of Japan's relaxing emergency
restrictions and as China's markets got busy before the
start of the lunar new year.

Europe then made a strong start to the week as higher oil
prices and inflation expectations lifted basic resource
and banking shares 2% and 1.5%, and France's Veolia
launched a hostile 11.3 billion-euro takeover bid for waste and
water rival Suez.

"A generalised risk-on tone is pushing stocks higher,"
UniCredit's analysts said in a note.

Bond markets were moving, too, as focus intensified on how
far inflation might rise if the current mix of stimulus, rising
oil and food prices and expectations for a reopening economies
continue to hold.

Ten-year U.S. Treasury yields, which are one of the main
drivers of global borrowing costs, climbed above 1.2% for the
first time since the peak of coronavirus uncertainty last March.

Break-even rates, which account for inflation, traded as
high as 2.21%, their highest since 2014 while in Europe,
Germany's 10-year yields were near five-month highs at -0.42%
, near .

"It will be hard not to see inflation in something when we
get what is likely to be a short-term stimulus boost," Deutsche
Bank's Jim Reid said, referring to planned U.S. stimulus.

"Whether that will be in goods, wages or asset prices or all
three remains to be seen, but it seems inevitable there will be
an impact."

That renewed focus on inflation came as Brent crude
touched an intraday high of $60.06 a barrel, the highest since
January last year.

Saudi Arabia's pledge of extra output cuts in February and
March on the back of reductions by other OPEC members its
allies, including Russia, is helping to limit supply and support
prices.

In a further sign of that supply dynamic, the six-month
Brent spread <LCOc1-LCOc7> hit its highest in more than year,
$2.45. OCBC's economist Howie Lee said the Saudis had sent
another "very bullish signal" last week too by keeping its Asian
prices unchanged.

"I don't think anybody dares to short the market when Saudi
is like this," he said.

STIMULUS

Asia's overnight rally had seen Japan's Nikkei close
up 2%, Chinese blue-chip shares advance 1.5% and
Australian shares finish 0.6% higher.

Wall Street futures were pointing 0.3% higher after the
Nasdaq and S&P 500 both climbed to record highs on Friday as
weak monthly U.S. jobs data supported expectations
of stimulus and after some strong corporate earning.

U.S. President Joe Biden and his Democratic allies in
Congress forged ahead with their stimulus plan on Friday as
lawmakers approved a budget outline that will allow them to
muscle through in the coming weeks without Republican support.

U.S. Treasury Secretary Janet Yallen predicted the United
States would reach full employment next year if Congress can
pass its support package.

"That's a big call, given full employment is 4.1%, but one
that will sit well with the market at a time when the
vaccination program is being rolled out efficiently in a number
of countries," said Chris Weston, Melbourne-based chief
strategist at Pepperstone.

Expectations of a U.S. economic recovery have not boosted
the dollar, however, "although much of the optimism towards U.S.
macro is probably well founded," said Kristoffer Kjær Lomholt,
chief analyst, FX and rates strategy at Danske Bank.

"The U.S. jobs recovery has more or less stalled (though),
and that did leave some space to take EUR/USD higher. The next
big theme that may be priced further in to spot is moving ahead
with U.S. fiscal talks."

Indeed, the dollar came off a four-month high against the
Japanese yen to be last at 105.50. The euro was
weaker again though at $1.2022 after rising 0.7% on Friday to a
one-week high.

Data showed German industry avoided a contraction in
December. Despite coronavirus lockdowns at home and abroad,
demand from China helped export-oriented manufacturers in
Europe's largest economy weather the COVID-19 pandemic.

The risk-sensitive Australian dollar eased from a
one-week high to $0.7655 while South Africa's rand fell
nearly 0.5% after its AstraZeneca vaccine troubles.

(Additional reporting by Swati Pandey in Sydney, editing by
Larry King)

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.